معرفی
Dr. Christina Elliott is a Postdoctoral Research Associate at the School of Cardiovascular & Metabolic Health, University of Glasgow. Her research focuses on neurodegenerative diseases, particularly Alzheimer's and multiple sclerosis, with expertise in molecular neuroscience, signal transduction, and neuroinflammatory mechanisms.
- Current Affiliation: University of Glasgow, School of Cardiovascular & Metabolic Health
- Email: Christina.Elliott@glasgow.ac.uk
- Lab Location: Lab 535, Wolfson Link, Glasgow, G12 8QQ
Her research bridges molecular biology and clinical neuroscience, with a strong emphasis on protein interactions (e.g., DISC1, PDE4D), biomarker discovery (REST in Alzheimer's), and therapeutic targeting of signaling pathways (Wnt-PCP, GSK3β). She has published extensively on synaptotoxicity, myelination, and neurogenetic mechanisms.
Key publication trends include neuroinflammatory pathways in multiple sclerosis, protein degradation systems (ubiquitin/SUMOylation), and phosphodiesterase inhibition for psychiatric and neurological conditions. Her work often combines experimental models (CHO cells, mouse models) with clinical data.
- 2024: Investigated PDE4B variants in PTSD models
- 2020: Elucidated tau pathology in Alzheimer's
- 2018: Four studies on Wnt signaling, DISC1 regulation, and amyloid toxicity
- 2016-2017: Explored IL-33/ST2 pathways, Canavan disease therapies, and DISC1 modifications
Her collaborative work spans neurology, psychiatry, and systems biology, with methodological strengths in proteomics, biomarker analysis, and transgenic models.
Dr. Elliott's research is hosted in Lab 535 at Wolfson Link, focusing on translating molecular insights into therapeutic strategies for neurodegenerative and psychiatric conditions.
